文献速递肾癌与肾肿瘤

局限性肾细胞癌根治性肾切除术后辅助放疗:系统综述与荟萃分析

Adjuvant Radiation Therapy After Radical Nephrectomy in Patients with Localized Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
PubMed 文献 · Eur Urol Oncol · 2018-11-05

该系统综述与荟萃分析纳入12项研究共1624例早期肾细胞癌根治性肾切除术后患者,其中10项为回顾性研究、2项为随机对照试验,37%接受辅助放疗,中位随访49个月。辅助放疗与5年无病生存和总生存改善无关,但与局部区域复发减少相关。作者指出适应证混杂可能影响结果。

要点

  • 辅助放疗与5年无病生存和总生存改善无关。
  • 辅助放疗与局部区域复发减少相关。
  • 结果需谨慎解读,因数据主要来自非随机研究,可能存在适应证混杂。

核心结论

  • 在承认主要来自非随机研究的数据合并可能产生适应证混杂的前提下,根治性肾切除术后辅助放疗与无病生存或总生存改善无关,但与局部区域复发减少相关。

研究设计与样本

  • 系统综述与荟萃分析,纳入12项研究共1624例早期肾细胞癌根治性肾切除术后患者,其中10项为回顾性研究、2项为随机对照试验。
  • 37%的患者接受了辅助放疗,中位随访49个月。
  • 无病生存的风险比采用通用逆方差法和随机效应模型进行加权合并。
  • 5年局部区域复发、无病生存和总生存的比值比采用Mantel-Haenszel随机效应模型进行加权合并。

主要发现

  • 辅助放疗与5年无病生存或总生存改善无关。
  • 辅助放疗与局部区域复发减少相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出,合并主要来自非随机研究的数据可能产生适应证混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adjuvant radiation therapy has been recommended for patients at higher risk of relapse from renal cell carcinoma (RCC) to improve disease-free survival (DFS) and overall survival (OS) after radical nephrectomy. OBJECTIVE: To quantify the benefit of adjuvant radiation therapy. EVIDENCE ACQUISITION: A systematic review of electronic databases identified publications exploring the association between adjuvant radiation therapy and locoregional recurrence (LRR), DFS, and OS among patients after radical nephrectomy for early-stage RCC. Hazard ratios for DFS were weighted and pooled using the generic inverse variance and random effects model. Odds ratios for LRR, DFS, and OS at 5yr were weighted and pooled in a meta-analysis using Mantel-Haenszel random-effects modeling. EVIDENCE SYNTHESIS: Twelve studies comprising 1624 patients were included in the analysis. Ten studies were retrospective and two were randomized controlled trials. Adjuvant radiation therapy was delivered to 37% of patients. The median follow-up was 49mo. Adjuvant radiation therapy was not associated with better DFS or OS at 5yr, but was associated with less LRR. CONCLUSIONS: With the caveat that confounding by indication may result from pooling data from predominantly nonrandomized studies, adjuvant radiation after radical nephrectomy was not associated with improved DFS or OS but was associated with less LRR. PATIENT SUMMARY: Radiation therapy after resection of renal cell carcinoma with a high risk of relapse may reduce the risk of local recurrence but not the risk of disease recurrence or death after 5yr.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Fernández IA, Rodríguez-Romo L, Hernandez-Barajas D, et al. Adjuvant Radiation Therapy After Radical Nephrectomy in Patients with Localized Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2018. PMID: 31277782. doi:10.1016/j.euo.2018.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。